PubMed

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.

Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A; PPP Collaborative Group.

Diabetes Care. 2003 Dec;26(12):3264-72.PMID: 14633812 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

de Gaetano G; Collaborative Group of the Primary Prevention Project.

Lancet. 2001 Jan 13;357(9250):89-95. Erratum in: Lancet 2001 Apr 7;357(9262):1134. PMID: 11197445 [PubMed - indexed for MEDLINE]Related articles

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y; Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators.

JAMA. 2008 Nov 12;300(18):2134-41. Epub 2008 Nov 9. Erratum in: JAMA. 2009 May 13;301(18):1882. PMID: 18997198 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.

Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):56-65.PMID: 15998891 [PubMed - indexed for MEDLINE]Related articlesFree article

Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.

[No authors listed]

J Cardiovasc Risk. 1995 Apr;2(2):137-42.PMID: 7606650 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.PMID: 15753114 [PubMed - indexed for MEDLINE]Related articlesFree article

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, Lee R, Bancroft J, MacEwan S, Shepherd J, Macfarlane P, Morris A, Jung R, Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese G, McKnight J, O'Brien I, Semple C, Petrie J, Gordon D, Pringle S, MacWalter R; Prevention of Progression of Arterial Disease and Diabetes Study Group; Diabetes Registry Group; Royal College of Physicians Edinburgh.

BMJ. 2008 Oct 16;337:a1840. doi: 10.1136/bmj.a1840.PMID: 18927173 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study.

Diabetes Care. 2002 Nov;25(11):1919-27.PMID: 12401733 [PubMed - indexed for MEDLINE]Related articlesFree article

Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

Berger JS, Krantz MJ, Kittelson JM, Hiatt WR.

JAMA. 2009 May 13;301(18):1909-19.PMID: 19436018 [PubMed - indexed for MEDLINE]Related articlesFree article

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.PMID: 12512736 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiplatelet therapy and anticoagulation in patients with hypertension.

Griffin G.

Am Fam Physician. 2005 Mar 1;71(5):897-9. Review.PMID: 15768617 [PubMed - indexed for MEDLINE]Related articles

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins.

De Berardis G, Sacco M, Evangelista V, Filippi A, Giorda CB, Tognoni G, Valentini U, Nicolucci A; ACCEPT-D Study Group.

Trials. 2007 Aug 28;8:21.PMID: 17725825 [PubMed - in process]Related articlesFree article

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

[No authors listed]

Lancet. 2000 Jan 22;355(9200):253-9. Erratum in: Lancet 2000 Sep 2;356(9232):860. PMID: 10675071 [PubMed - indexed for MEDLINE]Related articles

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

[No authors listed]

BMJ. 1994 Jan 8;308(6921):81-106. Erratum in: BMJ 1994 Jun 11;308(6943):1540. PMID: 8298418 [PubMed - indexed for MEDLINE]Related articlesFree article

The platelet in diabetes: focus on prevention of ischemic events.

Colwell JA, Nesto RW.

Diabetes Care. 2003 Jul;26(7):2181-8. Review.PMID: 12832332 [PubMed - indexed for MEDLINE]Related articlesFree article

Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.

Gerstein HC, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S.

Diabetes Care. 1996 Nov;19(11):1225-8.PMID: 8908384 [PubMed - indexed for MEDLINE]Related articles

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study.

Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE.

Arch Intern Med. 2007 Aug 13-27;167(15):1610-8.PMID: 17698683 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).

Knopp RH, d'Emden M, Smilde JG, Pocock SJ.

Diabetes Care. 2006 Jul;29(7):1478-85.PMID: 16801565 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR; HOPE and HOPE-TOO Trial Investigators.

JAMA. 2005 Mar 16;293(11):1338-47.PMID: 15769967 [PubMed - indexed for MEDLINE]Related articlesFree article

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL.

JAMA. 2006 Jan 18;295(3):306-13. Erratum in: JAMA. 2006 May 3;295(17):2002. PMID: 16418466 [PubMed - indexed for MEDLINE]Related articlesFree article